We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFIC:NASDAQFlushing Financial Corporation Analysis

Data as of 2026-04-02 - not real-time

$15.58

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading above its short‑term moving average while remaining just shy of the mid‑term average, with the RSI sitting in the mid‑50s that signals neutral momentum. A positive MACD histogram and a bullish MACD signal line suggest recent upside pressure, and the beta below one indicates lower sensitivity to broader market swings. Volume has been on the rise, supporting the technical narrative, though price is approaching a near‑term resistance zone identified by recent price action.
Fundamentally, the price‑to‑earnings multiple is roughly double the industry average, while the price‑to‑book ratio sits comfortably below one, hinting at a discount to book value. The dividend yield is notably high, but the payout ratio exceeds earnings, raising questions about sustainability. Analysts have recently nudged their price target upward by a modest amount, anchoring a fair‑value estimate near the current level, which aligns with the forward earnings multiple that appears attractive. Together, the technical strength, valuation nuances, and dividend concerns shape a cautious but potentially rewarding outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical positioning near short‑term resistance
  • Neutral momentum indicated by RSI
  • Dividend payout exceeding earnings

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive forward earnings multiple
  • Price below book value
  • Analyst target revisions supporting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential regulatory and credit risk in regional banking
  • Uncertain dividend sustainability
  • DCF fair‑value indicating possible overvaluation

Key Metrics & Analysis

Financial Health

Profit Margin8.35%
P/E Ratio28.9
ROE2.64%
ROA0.21%
P/B Ratio0.7
Op. Cash Flow$61.0M
Industry P/E16.6

Technical Analysis

TrendNeutral
RSI54.8
Support$14.55
Resistance$15.67
MA 20$15.12
MA 50$15.76
MA 200$14.46
MACDBullish
VolumeIncreasing
Fear & Greed Index77.61

Valuation

Fair Value$4.49
Target Price$16.80
Upside/Downside7.83%
GradeFair
TypeBlend
Dividend Yield5.71%

Risk Assessment

Beta0.81
Volatility28.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.